| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/15/2001 | WO2001018015A1 Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017669A1 Method and device for applying a plurality of microdroplets onto a substrate |
| 03/15/2001 | WO2001017547A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 03/15/2001 | WO2001017537A2 Methods and compositions for reducing immune response |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017514A1 Modulation of gene expression by modulating histone acetylation |
| 03/15/2001 | WO2001017344A2 A method of transgenic fowl construction |
| 03/15/2001 | WO2001017343A1 Methods for evaluating a compound for its effect on skin |
| 03/15/2001 | WO2001017334A1 Seedless fruit production |
| 03/15/2001 | WO2001017333A1 Transgenic fiber producing plants with increased expression of sucrose phosphate synthase |
| 03/15/2001 | WO2001017332A1 TRANSGENIC PLANTS CONTAINING dnaK GENE OR hsp70 GENE |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000073440A8 Pollinosis-associated gene 787 |
| 03/15/2001 | WO2000072182A3 Methods and system for amplitude normalization and selection of data peaks |
| 03/15/2001 | WO2000070061A3 Senescence-related promoters |
| 03/15/2001 | WO2000070037A3 Directed evolution of microorganisms |
| 03/15/2001 | WO2000068389A3 Auxin transport proteins |
| 03/15/2001 | WO2000068375A3 Modified pm and pu promoters of tol plasmids |
| 03/15/2001 | WO2000068362A3 Undifferentiated erythroid cells and their use in ligand binding assays |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000066154A3 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 03/15/2001 | WO2000065061A3 Nucleic acid sequences from candida yeasts which code cytochrome b5 polypeptides |
| 03/15/2001 | WO2000061798A3 Method for mapping a dna molecule comprising an ad infinitum amplification step |
| 03/15/2001 | WO2000061610A3 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 03/15/2001 | WO2000055338A9 Sesquiterpenoid synthase genes and their use for influencing bitterness and resistance in plants |
| 03/15/2001 | WO2000053730A3 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 03/15/2001 | WO2000049167A8 Latency-associated regulatory region from herpesvirus saimiri (hvs) |
| 03/15/2001 | WO2000047733A9 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 03/15/2001 | WO2000046402A8 Genomic analysis method |
| 03/15/2001 | WO2000042196B1 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome |
| 03/15/2001 | WO2000029603A8 Low cost manufacture of oligosaccharides |
| 03/15/2001 | WO2000014263A8 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them |
| 03/15/2001 | WO1999054454A9 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943587A1 Neue für das dapF-Gen codierende Nukleotidsequenzen New coding for the dapF gene nucleotide sequences |
| 03/15/2001 | DE19942149A1 Verfahren zur Expression von exogenen Sequenzen in Säugerzellen A process for the expression of exogenous sequences in mammalian cells |
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE19925073A1 Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung Nucleic acid molecules with specific detection of native PrP c · S · · ·, production and use |
| 03/15/2001 | DE10044468A1 New nucleic acid encoding delta-6-desaturase, useful for producing ciliates and plants that overproduce unsaturated fatty acids, derived from Tetrahymena |
| 03/15/2001 | DE10014639A1 cDNSen mit einer Kodierung von Enzymen zur Fructan-Synthese mit einer Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNSen with a coding for enzymes of fructan synthesis with a low-temperature expression as well as methods for their isolation |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2403330A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384496A1 Luciferase expression cassettes and methods of use |
| 03/15/2001 | CA2384456A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384368A1 Method of detecting of screening cancer or precancer by determining the amount and integrity of nucleic acids |
| 03/15/2001 | CA2384123A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 03/15/2001 | CA2384113A1 Method and system for non-random selection of plant and tissue products |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384014A1 Nucleic and amino acid sequences relating to resistance to blackleg in plants |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2384000A1 Regulatory sequences and expression systems functioning in filamentous fungi |
| 03/15/2001 | CA2383885A1 Crystal structure of a deacetylase and inhibitors thereof |
| 03/15/2001 | CA2383857A1 Detection of alterations in a gene by long range pcr using human mobile elements |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383767A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | CA2383638A1 Monomeric analogues of human insulin |
| 03/15/2001 | CA2383563A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | CA2383321A1 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | CA2383186A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382434A1 Device for introducing pores into biological materials |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2382138A1 Methods and compositions for reducing immune response |
| 03/15/2001 | CA2379536A1 Dihydroorotase extracted from plants |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | CA2377905A1 Method and reagent for detection of trichothecene mycotoxins |
| 03/15/2001 | CA2376106A1 Paramyxoviruses comprising modified transcription start sequence |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/15/2001 | CA2349413A1 Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2318507A1 Novel nucleotide sequences coding for the pgi gene |
| 03/14/2001 | EP1083233A1 Production of natural flavors by laccase catalysis |
| 03/14/2001 | EP1083232A1 Transfer of mRNA using polycationic compounds |
| 03/14/2001 | EP1083231A1 Smooth muscle cell promoter and uses thereof |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083229A1 Modified adenoviral vectors for use in gene therapy |
| 03/14/2001 | EP1083228A1 Modified adenoviral vectors for use in gene therapy |
| 03/14/2001 | EP1083227A1 Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
| 03/14/2001 | EP1083226A1 Cell separation device and separation method |
| 03/14/2001 | EP1083225A1 Method for the fermentative production of D-pantothenic acid using coryneform bacteria |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |